Lupin gets USFDA nod for hypertension treatment drug in US
"It has received tentative (rpt) tentative approval for Olmesartan medoximil tablets, 5 mg, 20 mg and 40 mg from the US Food and Drug Administration (USFDA)," Lupin said in a BSE filing on Monday. Image Source: Reuters